摘要
急性肾损伤是一种复杂的疾病,死亡率和发病率都在不断上升。炎症反应,包括先天免疫反应和适应性免疫反应,参与了机体的启动和发育。F急性肾损伤,尤其是缺血性肾损伤。肾小管细胞和不同的免疫细胞亚群在炎症的发病机制中起着至关重要的作用。基因治疗现状现在他们在肾脏修复方面的好处。在这里,我们回顾了肾脏炎症浸润,炎症介质,氧化应激和潜在的信号通路,这些都是导致肾衰竭的原因。SE在急性肾损伤机制中的作用。最近的研究在了解炎症相关肾损伤的病理生理过程方面显示出不同的见解,并为临床提供了新的治疗方法。RGS通过平衡修复和预防损伤来改善急性肾损伤。有趣的是,靶序列的反义寡核苷酸,局部选择转移N实体器官和腺病毒介导的某些基因过表达是缓解急性肾损伤的有效策略。
关键词: 急性肾损伤,炎症,细胞因子,氧化应激,基因治疗,树突状细胞。
Current Gene Therapy
Title:Current Understanding of Inflammatory Responses in Acute Kidney Injury
Volume: 17 Issue: 6
关键词: 急性肾损伤,炎症,细胞因子,氧化应激,基因治疗,树突状细胞。
摘要: Acute kidney injury has been a tough complex with increased mortality and morbidity. Inflammatory responses, including innate and adaptive immune responses, involve in the initiation and development of acute kidney injury, especially under the ischemic circumstances. Tubular cells and distinct immune cell subgroups play a critical role in the pathogenesis of inflammation. Current gene therapies show their benefits in renal repair. Here, we reviewed the renal inflammatory infiltration, inflammatory mediators, oxidative stress and potential signaling pathways, which give rise to the kidney diseases, in the mechanism of acute kidney injury. Recent studies showed diverse insights in understanding the pathophysiological process of inflammation related renal injury and provided novel clinical targets for ameliorating acute kidney injury by balancing the facilitation of repairing and prevention of impairing. Interestingly, antisense oligonucleotides of target sequence, local electransfering on solid organ and adenovirus-mediated certain gene overexpression have been promising strategies in alleviating acute kidney injury.
Export Options
About this article
Cite this article as:
Current Understanding of Inflammatory Responses in Acute Kidney Injury, Current Gene Therapy 2017; 17 (6) . https://dx.doi.org/10.2174/1566523218666180214092219
DOI https://dx.doi.org/10.2174/1566523218666180214092219 |
Print ISSN 1566-5232 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5631 |
Call for Papers in Thematic Issues
Programmed Cell Death Genes in Oncology: Pioneering Therapeutic and Diagnostic Frontiers (BMS-CGT-2024-HT-45)
Programmed Cell Death (PCD) is recognized as a pivotal biological mechanism with far-reaching effects in the realm of cancer therapy. This complex process encompasses a variety of cell death modalities, including apoptosis, autophagic cell death, pyroptosis, and ferroptosis, each of which contributes to the intricate landscape of cancer development and ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Aldose Reductase: A Multi-disease Target
Current Enzyme Inhibition Endogenous Cardioprotective Agents: Role in Pre and Postconditioning
Current Drug Targets Skin Prick Test with Self-Saliva in Patients with Oral Aphthoses: A New Diagnostic Pathergy for Behcets Disease and Recurrent Aphthosis
Inflammation & Allergy - Drug Targets (Discontinued) Update on Pharmacologic Retinal Vascular Toxicity
Current Pharmaceutical Design Dynamic Role of Microparticles in Type 2 Diabetes Mellitus
Current Diabetes Reviews Transitional Connective Tissue Diseases: Description of Four Cases
Current Rheumatology Reviews Various Non-Injectable Delivery Systems for the Treatment of Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Current Role of Leukotriene Receptor Antagonists in Preschool Asthma
Current Respiratory Medicine Reviews Medication-Induced Acute Abdominal Pain: Evaluation with CT Imaging
Current Medical Imaging Cell Cycle Arrest as a Therapeutic Target of Acute Kidney Injury
Current Protein & Peptide Science Modelling the Neurovascular Unit and the Blood-Brain Barrier with the Unique Function of Pericytes
Current Neurovascular Research Mechanisms of HIV Transcriptional Regulation by Drugs of Abuse
Current HIV Research Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research Safety of Dipeptidyl Peptidase 4 Inhibitors for Treatment of Type 2 Diabetes
Current Drug Safety Anti Citrullinated Protein Antibodies and Mechanism of Action of Common Disease Modifying Drugs - Insights in Pathomechanisms of Autoimmunity
Current Pharmaceutical Design Perivascular Adipose Tissue, Inflammation and Vascular Dysfunction in Obesity
Current Vascular Pharmacology Emerging Peptide Therapeutics for Inflammatory Autoimmune Diseases
Current Pharmaceutical Design Skeletal Muscle in Cancer Cachexia: The Ideal Target of Drug Therapy
Current Cancer Drug Targets Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design Near Infrared Spectroscopy in Healthy Preterm and Term Newborns: Correlation with Gestational Age and Standard Monitoring Parameters
Current Neurovascular Research